Publications

A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R Fl)

AuthID
P-00X-4CE

Author(s)

Palomba, ML

Ghione, P

Patel, AR

Deighton, K

Jacobson, C

Nahas, M

Jung, AS

Hatswell, AJ

Kanters, S

Limbrick Oldfield, E

Wade, SW

Snider, JT

Neelapu, SS

Riberio, MT

Gribben, J

Radford, J

Bobillo, S

Ghesquieres, H

Document Type

Abstract

Year published

2021

Published

in BLOOD, ISSN: 0006-4971

Volume: 138

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1182/blood-2021-147608

Wos: WOS:000736413906109

Source Identifiers

ISSN: 0006-4971

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R Fl)

Useful Links

Get Help

Federated Authentication (Click on the image)

A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R Fl)

Useful Links

Get Help